AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Total Equity · Q3 FY2025 · quarter ended Sep 2025
Total equity of €146.93M in Q3 FY2025
Q3 FY2025 total equity was €146.93M.
Context
- Total equity amounted to 88.7% of total assets at the end of Q3 FY2025.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
Currency unavailable · from the balance sheet
No Total Equity data reported for this period type.
Total Equity vs competitors
How AGMB compares with its peers on the latest reported figures
- Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
- Total equity amounts to 88.7% of total assets for AGMB, versus a peer median of 76.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $452.16M USD | -6.8% | — | 80.7% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €146.93M EUR | — | — | 88.7% |
| Mar 2026 | $143.65M USD | -0.3% | -19.5% | 72.3% | |
| Mar 2026 | $59.49M USD | +462.4% | -3.6% | 94.3% | |
| Mar 2026 | $12.75M USD | -62.5% | -47.8% | 3.9% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | -3.6% | -19.5% | 76.5% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.